[1] Wu CT, Morris JR. Genes, genetics, and epigenetics: a correspondence. Science, 2001, 293(5532): 1103–1105. <\p>

[2] Pennisi E. Behind the scenes of gene expression. Science, 2001, 293(5532): 1064–1067. <\p>

[3] Dennis C. Epigenetics and disease: Altered states. Nature, 2003, 421(6924): 686–688. <\p>

[4] 薛开先主编. 肿瘤表遗传学. 北京: 科学出版社, 2011: 1–35. <\p>

[5] Cloud J. Why DNA isn’t your destiny. Time, 6 January, 2010. <\p>

[6] Watters E. DNA is not destiny. Discover, 22 November, 2006. <\p>

[7] Ebrahim S. Epigenetics: the next big thing. Int J Epide-miol, 2012, 41(1): 1–3. <\p>

[8] Kubota T, Hata K. Epigenomics comes of age with ex-panding roles in biological understanding and clinical ap-plication. J Hum Genet, 2013, 58(7): 395. <\p>

[9] Williams SCP. Core concepts: Epigenetics. Proc Natl Acad Sci USA, 2013, 110(9): 3209. <\p>

[10] Holliday R. Epigenetics: a historical overview. Epigenet-ics, 2006, 1(2): 76–80. <\p>

[11] Felsinfeld G. A brief history of epigenetics. In: Allis CD, Jenuwein T, Reinberg D. Epigenetics. Cold Spring Harbor: Cold Spring Harbor Lab Press, 2007: 15–22. <\p>

[12] Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science, 1975, 187(4173): 226–232. <\p>

[13] Feinberg AP. Epigenetics at the epicenter of modern medicine. JAMA, 2008, 299(11): 1345–1350. <\p>

[14] 薛开先. 肿瘤研究中的表遗传学与遗传学及其存在问题和前景(1). 国际遗传学杂志, 2012, 35(2): 125–133. <\p>

[15] Paoloni–Giacobino A. Post genomic decade––the epigenome and exposome challenges. Swiss Med Wkly, 2011, 141: w13321. <\p>

[16] Abbott A. Editorial. The human genome at ten. Nature, 2010, 464(7289): 649–650. <\p>

[17] 薛开先. 表遗传学推动新一轮遗传学的发展. 遗传, 2005, 27(1): 155–159. <\p>

[18] Feinberg AP. Cancer epigenetics takes center stage. Proc Natl Acad Sci USA, 2001, 98(2): 392–394. <\p>

[19] Laird CD, Pleasant ND, Clark AD, Sneeden JL, Hassan KMA, Manley NC, Vary JC Jr, Morgan T, Hansen RS, Stöger R. Hairpin–bisulfite PCR: assessing epigenetic methylation patterns on complementary strands of indi-vidual DNA molecules. Proc Natl Acad Sci USA, 2004, 101(1): 204–209. <\p>

[20] Kovalchuk I. Transgenerational epigenetic inheritance in animals. Front Genet, 2012, 3: 76. <\p>

[21] Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene, 2001, 20(24): 3139–3155. <\p>

[22] Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene, 2001, 278(1–2): 25–31. <\p>

[23] Zheng YG, Wu J, Chen ZY, Goodman M. Chemical regu-lation of epigenetic modifications: Opportunities for new cancer therapy. Med Res Rev, 2008, 28(5): 645–687. <\p>

[24] Delcuve GP, Rastegar M, Davie JR. Epigenetic control. J Cell Physiol, 2009, 219(2): 243–250. <\p>

[25] Tost J. DNA methylation: an introduction to the biology and the disease–associated changes of a promising bio-marker. Methods Mol Biol, 2009, 507: 3–20. <\p>

[26] Cavalli G. From linear genes to epigenetic inheritance of three–dimensional epigenomes. J Mol Biol, 2011, 409(1): 54–61. <\p>

[27] Baylin SB, Jones PA. A decade of exploring the cancer epigenome – biological and translational implications. Nat Rev Cancer, 2011, 11(10): 726–734. <\p>

[28] 薛开先. 肿瘤表基因组研究. 国际遗传学杂志, 2012, 35(1): 47–55. <\p>

[29] Zhao Q, Zhang Y. Epigenome sequencing comes of age in development, differentiation and disease mechanism re-search. Epigenomics, 2011, 3(2): 207–220. <\p>

[30] Csoka AB, Szyf M. Epigenetic side–effects of common p